Elevance Health, Inc. (ELV) is listed on NYSE in Insurance Stocks. It is $394.42, -1.18%, with a $85.5B market cap. RSI is 51.1, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 51.1 Neutral
Market Cap $85.5B
Volume 525.9K
Fundamentals — 10-Q Q2 2026
Revenue $100.7B
Net Income $3.2B
EPS $14.73
Gross Margin 89.1%
Operating Margin 3.8%
Net Margin 3.2%
Debt / Equity 0.7x
P/E Ratio 26.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Peru Ramiro G | Director | Buy | 1,000 | $366.05 | $366,050 | 2026 Jul 17 |
| Boudreaux Gail | President and CEO | Buy | 2,725 | $367.79 | $1.0M | 2026 Jul 17 |
| Penczek Ronald W | CAO & Controller | Sell | 369 | $403.16 | $148,766 | 2026 Jun 12 |
| Dixon Robert L JR | Director | Sell | 151 | $401.77 | $60,667 | 2026 Jun 11 |
| Penczek Ronald W | CAO & Controller | Sell | 1,531 | $403.13 | $617,192 | 2026 May 19 |
| Schulman Amy W | Director | Sell | 26 | $287.50 | $7,475 | 2026 Mar 12 |
| Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 3,196 | $284.92 | $910,604 | 2026 Mar 6 |
| Collis Steven H | Director | Buy | 3,000 | $289.84 | $869,520 | 2026 Mar 5 |
| DeVore Susan D. | Director | Buy | 1,200 | $312.15 | $374,580 | 2025 Aug 19 |
| Boudreaux Gail | President and CEO | Buy | 8,500 | $286.94 | $2.4M | 2025 Jul 18 |
| Kaye Mark | EVP & CFO | Sell | 4,588 | $424.82 | $1.9M | 2025 Apr 24 |
| Penczek Ronald W | CAO & Controller | Sell | 443 | $415.13 | $183,903 | 2025 Mar 10 |
| Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 3,504 | $396.30 | $1.4M | 2025 Mar 5 |
| Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 7,417 | $432.14 | $3.2M | 2024 Oct 18 |
| Peru Ramiro G | Director | Sell | 753 | $531.52 | $400,235 | 2024 Aug 5 |
| Boudreaux Gail | President and CEO | Sell | 34,000 | $500.98 | $17.0M | 2024 Jul 22 |
| Dixon Robert L JR | Director | Sell | 305 | $506.76 | $154,562 | 2024 Jul 19 |
| Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 20,310 | $533.34 | $10.8M | 2024 Apr 24 |
| Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,432 | $500.46 | $1.2M | 2024 Mar 8 |
| Penczek Ronald W | CAO & Controller | Sell | 916 | $504.58 | $462,195 | 2024 Mar 6 |
Other Insurance Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $505.05 | 54.9 | -- |
| | $392.99 | 41.4 | $352.7B |
| | $192.63 | 57.7 | $91.9B |
| | $96.50 | 56.2 | $61.3B |
| | $64.74 | 47.3 | $32.0B |
| | $116.52 | 37.5 | $58.4B |
| | $355.47 | 49.3 | $75.4B |
| | $98.83 | 45.5 | $33.7B |
Take ELV further
- Browse Insurance Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ELV in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Elevance Health, Inc. next reports.
Set alerts on ELV
Get notified when Elevance Health, Inc. hits your price targets or technical conditions are met.
Get Started Free